Minimum end‐tidal sevoflurane concentration necessary to prevent movement during a constant rate infusion of morphine,or morphine plus dexmedetomidine in ponies |
| |
| Authors: | Miguel Gozalo‐Marcilla Klaus Hopster Frank Gasthuys Anna Elisabeth Krajewski Andrea Schwarz Stijn Schauvliege |
| |
| Affiliation: | 1. Department of Surgery and Anaesthesia of Domestic Animals, Faculty of Veterinary Medicine, University of Ghent, , Merelbeke, Belgium;2. Clinic for Horses, University of Veterinary Medicine Hannover, , Hannover, Germany;3. Equine Department, Section Anaesthesiology, Vetsuisse Faculty, University of Zürich, , Zürich, Switzerland |
| |
| Abstract: | ObjectiveTo compare the effects of a constant rate infusion (CRI) of dexmedetomidine and morphine to those of morphine alone on the minimum end-tidal sevoflurane concentration necessary to prevent movement (MACNM) in ponies.Study designProspective, randomized, crossover, ‘blinded’, experimental study.AnimalsFive healthy adult gelding ponies were anaesthetized twice with a 3-week washout period.MethodsAfter induction of anaesthesia with sevoflurane in oxygen (via nasotracheal tube), the ponies were positioned on a surgical table (T0), and anaesthesia was maintained with sevoflurane (Fe‘SEVO 2.5%) in 55% oxygen. Monitoring included pulse oximetry, electrocardiography and measurement of anaesthetic gases, arterial blood pressure and body temperature. The ponies were mechanically ventilated and randomly allocated to receive IV treatment M [morphine 0.15 mg kg?1 (T10-T15) followed by a CRI (0.1 mg kg?1 hour?1)] or treatment DM [dexmedetomidine 3.5 μg kg?1 plus morphine 0.15 mg kg?1 (T10-T15) followed by a CRI of dexmedetomidine 1.75 μg kg?1 hour?1 and morphine 0.1 mg kg?1 hour?1]. At T60, a stepwise MACNM determination was initiated using constant current electrical stimuli at the skin of the lateral pastern region. Triplicate MACNM estimations were obtained and then averaged in each pony. Wilcoxon signed-rank test was used to detect differences in MAC between treatments (a = 0.05).ResultsSevoflurane-morphine MACNM values (median (range) and mean ± SD) were 2.56 (2.01–4.07) and 2.79 ± 0.73%. The addition of a continuous infusion of dexmedetomidine significantly reduced sevoflurane MACNM values to 0.89 (0.62–1.05) and 0.89 ± 0.22% (mean MACNM reduction 67 ± 11%).Conclusion and clinical relevanceCo-administration of dexmedetomidine and morphine CRIs significantly reduced the MACNM of sevoflurane compared with a CRI of morphine alone at the reported doses. |
| |
| Keywords: | constant‐rate infusion dexmedetomidine minimal alveolar concentration morphine ponies sevoflurane |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
